Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT06964568 2026-02-10

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

Phase 3 Recruiting

452 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT06610734 2026-02-09

SKY

Phase 2 Recruiting

202 enrolled

Thoracic

Small Cell Lung Cancer Extensive Stage

NCT05358938 2026-02-06

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Phase EARLY_PHASE1 Active not recruiting

22 enrolled

Dermatologic

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell

NCT07385989 2026-02-04

Golidocitinib Combined With P-GemOx Plus PD-1 Inhibitor Versus P-GemOx Plus PD-1 Inhibitor in First-Line Newly Diagnosed Advanced or Non-Nasal Extranodal NK/T-Cell Lymphoma

Phase 2 Not yet recruiting

40 enrolled

Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT06710847 2026-02-02

SYLVER

Phase 1/2 Active not recruiting

14 enrolled

GastrointestinalGynecologic

Turcot syndrome, Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06627712 2026-01-30

SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC

Phase 3 Recruiting

318 enrolled

Breast

Triple Negative Breast Neoplasms

NCT05166239 2026-01-23

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

Phase 2 Completed

66 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT07363369 2026-01-23

Exploratory Clinical Study of FAP mRNA Vaccine in Patients With Advanced Malignant Solid Tumors

Phase 1 Not yet recruiting

10 enrolled

Other solid neoplasm

Advanced Malignant Solid Tumors

NCT07364305 2026-01-23

Lalo

Phase 2 Recruiting

50 enrolled

ICC

NCT04995003 2026-01-22

HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

Phase 1 Recruiting

25 enrolled

Sarcoma

Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial

NCT06190275 2026-01-21

Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Tumors

Phase NA Recruiting

12 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07339488 2026-01-14

ILDR-03

Phase 2 Active not recruiting

43 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT07327411 2026-01-08

Cetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid Tumors

Phase 2 Not yet recruiting

40 enrolled

Other solid neoplasm

Advanced Refractory Solid Tumors

NCT07317778 2026-01-05

Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer

Phase 2 Not yet recruiting

249 enrolled

Breast

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

NCT07230639 2025-12-26

MODIFI-CC

Phase 2 Recruiting

52 enrolled

Neoadjuvant Therapies

NCT07279077 2025-12-26

MODIFI-L

Phase 2 Recruiting

38 enrolled

Gastrointestinal

Colonic Neoplasms